CompanyGraph
Ansell Limited
ANN · ASX · Australia
Price data from its ANN listing on CXA
ansell.comFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $4.25B, above the global median of $1.2B
- FinancialsAltman Z-Score 3.32: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.70%Above 5Y avg (2.69%)
Annual Rate
AUD 1.16Paid semi-annual
Payout Ratio
37.7%Sustainable
Last Ex-Dividend
Aug 31, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.98BAUD4.25B · vs all stocks (USD)
Trailing P/E
21.02xvs Medical Instruments & Supplies peers
Revenue (TTM)
3.00BAUD2.14B · vs all stocks (USD)
Profit Margin
9.75%vs Medical Instruments & Supplies peers
Beta
0.5980xvs all stocks
52-Week Change
29.82%vs all stocks
Forward Annual Dividend Yield
2.70%vs all stocks
Market Capitalization
5.98BAUD4.25B · vs all stocks (USD)
Enterprise Value
9.11BAUD6.48B · vs all stocks (USD)
Trailing P/E
21.02xvs Medical Instruments & Supplies peers
Forward P/E
17.20xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
2.81xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
2.13xvs Medical Instruments & Supplies peers
Enterprise to Revenue
3.03xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
17.41xvs Medical Instruments & Supplies peers
Profit Margin
9.75%vs Medical Instruments & Supplies peers
Operating Margin
15.72%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
6.08%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
10.47%vs Medical Instruments & Supplies peers
Revenue (TTM)
3.00BAUD2.14B · vs all stocks (USD)
Revenue per Share (TTM)
14.99AUDUpdated Sep 23, 2026Quarterly Revenue Growth
13.20%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.25BAUD885.07M · vs all stocks (USD)
EBITDA (TTM)
399.10MAUD283.72M · vs all stocks (USD)
Net Income (TTM)
292.86MAUD208.19M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
157.10%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
545.57MAUD387.84M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
290.69MAUD206.65M · vs all stocks (USD)
Forward Annual Dividend Rate
1.16AUDUpdated Sep 23, 2026Forward Annual Dividend Yield
2.70%vs all stocks
Trailing Annual Dividend Rate
0.9556AUDUpdated Sep 23, 2026Trailing Annual Dividend Yield
2.23%vs all stocks
5-Year Average Dividend Yield
2.69%vs all stocks
Payout Ratio
37.74%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
19.10MUSDFY2025 · Jun 30, 2025Revenue
2.00BUSDFY2025 · Jun 30, 2025Cost of Goods Sold
1.18BUSDFY2025 · Jun 30, 2025Gross Profit
825.00MUSDFY2025 · Jun 30, 2025Operating Income
109.10MUSDvs all stocks (USD)
Pre-tax Income
143.90MUSDFY2025 · Jun 30, 2025Income Tax Expense
40.30MUSDFY2025 · Jun 30, 2025Net Income
103.60MUSDFY2025 · Jun 30, 2025EBIT
185.40MUSDFY2025 · Jun 30, 2025EBITDA (Income Statement)
260.20MUSDFY2025 · Jun 30, 2025Selling, General & Administrative
641.10MUSDFY2025 · Jun 30, 2025Non-operating Interest Income
6.30MUSDFY2025 · Jun 30, 2025Non-operating Interest Expense
41.50MUSDFY2025 · Jun 30, 2025EPS (Basic)
0.6990USDFY2025 · Jun 30, 2025EPS (Diluted)
0.6950USDFY2025 · Jun 30, 2025Basic Shares Outstanding
145.30MSharesFY2025 · Jun 30, 2025Diluted Shares Outstanding
145.30MSharesFY2025 · Jun 30, 2025Minority Interests (P&L)
-2.00MUSDFY2025 · Jun 30, 2025Cash & Cash Equivalents (End of Period)
238.30MUSDFY2025 · Jun 30, 2025Income Tax Paid
45.40MUSDFY2025 · Jun 30, 2025Capital Expenditures
-68.00MUSDFY2025 · Jun 30, 2025Net Acquisitions
-635.10MUSDFY2025 · Jun 30, 2025Purchase of Investments
-200.00KUSDFY2025 · Jun 30, 2025Net Investing Cash Flow
-703.30MUSDFY2025 · Jun 30, 2025Long-term Debt Issuance
35.30MUSDFY2025 · Jun 30, 2025Long-term Debt Payments
-117.30MUSDFY2025 · Jun 30, 2025Common Stock Repurchase
-4.40MUSDFY2025 · Jun 30, 2025Common Dividends Paid
-63.70MUSDFY2025 · Jun 30, 2025Other Financing Charges
-20.10MUSDFY2025 · Jun 30, 2025Net Financing Cash Flow
-170.20MUSDFY2025 · Jun 30, 2025Shares Outstanding
139.40MSharesUpdated Sep 23, 2026Float Shares
138.40MSharesUpdated Sep 23, 2026% Held by Insiders
1.57%vs all stocks
% Held by Institutions
64.68%vs all stocks
Total Cash (MRQ)
350.28MAUD249.01M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.79AUDUpdated Sep 23, 2026Total Debt (MRQ)
1.06BAUD755.12M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3742xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
2.29xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
20.03AUDUpdated Sep 23, 2026Total Assets
3.32BUSDvs all stocks (USD)
Total Current Assets
1.11BUSDFY2025 · Jun 30, 2025Total Liabilities
1.34BUSDFY2025 · Jun 30, 2025Total Non-current Assets
2.21BUSDFY2025 · Jun 30, 2025Total Non-current Liabilities
817.70MUSDFY2025 · Jun 30, 2025Total Current Liabilities
522.00MUSDFY2025 · Jun 30, 2025Cash
88.50MUSDFY2025 · Jun 30, 2025Cash Equivalents
149.80MUSDFY2025 · Jun 30, 2025Cash & Cash Equivalents
238.30MUSDFY2025 · Jun 30, 2025Accounts Receivable
306.90MUSDFY2025 · Jun 30, 2025Inventory
584.70MUSDFY2025 · Jun 30, 2025Accounts Payable
250.90MUSDFY2025 · Jun 30, 2025Short-term Debt
81.00MUSDFY2025 · Jun 30, 2025Deferred Revenue
20.90MUSDFY2025 · Jun 30, 2025Long-term Debt
724.60MUSDFY2025 · Jun 30, 2025Other Non-current Liabilities
26.40MUSDFY2025 · Jun 30, 2025Common Stock (Book)
1.03BUSDFY2025 · Jun 30, 2025Retained Earnings
1.10BUSDFY2025 · Jun 30, 2025Total Shareholders' Equity
1.98BUSDvs all stocks (USD)
52-Week Low
25.05AUDUpdated Sep 23, 202652-Week High
43.19AUDUpdated Sep 23, 202652-Week Change
29.82%vs all stocks
Beta
0.5980xvs all stocks
50-Day MA
36.83AUDUpdated Sep 23, 2026200-Day MA
32.06AUDUpdated Sep 23, 2026Avg 10-Day Volume
477.31KSharesUpdated Sep 23, 2026Avg 30-Day Volume
684.12KSharesUpdated Sep 23, 2026Diluted EPS (TTM)
2.03AUDUpdated Sep 23, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.32: safe zoneNotable
Altman Z-Score: 3.32
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $4.25B, above the global median of $1.2BNotable
Market cap (USD): 4,251,723,794.217Global Median: 1,201,862,193
Revenue is $2.14B, above the global median of $558.46MNotable
Revenue (USD): 2,136,019,925.525Global Median: 558,459,881.051
Levered free cash flow is $206.65M, above the global median of $18.92MNotable
Levered free cash flow (USD): 206,645,612.012Global Median: 18,920,810.7
Companies that share the same coordination system — how they create, deliver, or capture value.
State Grid Yingda Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Wonik Ips Co., Ltd
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Sanxiang Advanced Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Kinik Company
Tier 1ProductionThroughput-Bound ConversionFlowRule
Enphase Energy Inc.
Tier 1ProductionThroughput-Bound ConversionRuleInterface
Chongqing Changan Automobile Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Enel Generación Chile S.A.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Forehope Electronic Ningbo Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Franklin Electric Co., Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Shanghai Sinyang Semiconductor Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow